Latest Uveal melanoma Stories
Single-center experience in Europe illustrates safe control of hepatic metastases with the Delcath Hepatic CHEMOSAT Delivery System NEW YORK, May 29, 2015 /PRNewswire/ -- Delcath Systems,
DALLAS, May 19, 2015 /PRNewswire/ -- This melanoma treatment market (therapeutics) report analyzes treatment usage patterns, drug types available and pipeline and market
- Array regained worldwide rights to binimetinib and acquired worldwide rights to encorafenib - BOULDER, Colo., May 4, 2015 /PRNewswire/ -- Array BioPharma Inc.
OXFORD, England, April 20, 2015 /PRNewswire/ -- IMCgp100 shows partial and complete durable responses in Phase I/IIa trial in
Single-center, retrospective study evaluates Hepatic Progression Free Survival and Overall Survival after Regional Therapy NEW YORK, March 27, 2015 /PRNewswire/ -- Delcath Systems,
NEW YORK, March 9, 2015 /PRNewswire/ -- Delcath Systems, Inc.
Celebrities and Golf Enthusiasts Round Up Against Melanoma HOLLYWOOD, Calif., Oct.
- Median overall survival is encouraging for this patient population - BOULDER, Colo., Sept.
Statement from Tim Turnham, Executive Director, Melanoma Research Foundation WASHINGTON, Sept.
- An uxorious, effeminate, or spiritless man.
- A timorous, cowardly fellow.